早发性结直肠癌按详细解剖部位划分的分子特征:与晚发性病例的比较
该研究纳入14004例结直肠癌(含3089例早发性),比较盲肠至直肠各亚部位微卫星不稳定、CpG岛甲基化表型及KRAS、BRAF突变在早发性与晚发性病例间的差异。早发性肿瘤MSI-high比例在直肠最低(8.8%)、升结肠最高(46%),CIMP-high和BRAF突变比例亦呈部位梯度(趋势P<0.001)。多数亚部位早发性肿瘤MSI-high比例高于晚发性,CIMP-high和BRAF突变比例低于晚发性。
要点
- 早发性结直肠癌MSI-high比例自直肠8.8%至升结肠46%呈逐渐升高趋势(趋势P<0.001)。
- 多数亚部位早发性肿瘤MSI-high比例高于晚发性,CIMP-high和BRAF突变比例低于晚发性。
- 晚发性MSI-high肿瘤KRAS突变比例自直肠36%至升结肠9%持续下降(趋势P<0.001),盲肠回升至14%;早发性无此趋势。
核心结论
- 研究结果支持结直肠癌在不同结直肠亚部位和年龄组间存在生物地理学和致病异质性。
研究设计与样本
- 基于14004例结直肠癌病例(含3089例早发性病例)的分析,比较盲肠、升结肠、横结肠、降结肠、乙状结肠和直肠癌中MSI、CIMP及KRAS、BRAF突变,并比较早发性与晚发性病例。
主要发现
- 早发性肿瘤MSI-high、CIMP-high和BRAF突变比例在直肠最低(分别为8.8%、3.4%、3.5%),在升结肠最高(MSI-high 46%;CIMP-high 15%)或横结肠最高(BRAF突变8.6%),自直肠至升结肠趋势P<0.001。
- 与晚发性肿瘤相比,早发性肿瘤在多数亚部位MSI-high比例更高,CIMP-high比例和BRAF突变比例更低。
- 无论早发性还是晚发性肿瘤,盲肠KRAS突变比例均高于其他亚部位(P<0.001)。
- 晚发性MSI-high肿瘤KRAS突变比例自直肠(36%)至升结肠(9%)持续下降(趋势P<0.001),随后在盲肠回升(14%);早发性MSI-high癌未显示该趋势。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Early-onset colorectal cancer diagnosed before the age of 50 years has been increasing. Likely reflecting the pathogenic role of the intestinal microbiome, which gradually changes across the entire colorectal length, the prevalence of certain tumor molecular characteristics gradually changes along colorectal subsites. Understanding how colorectal tumor molecular features differ by age and tumor location is important in personalized patient management. METHODS: Using 14,004 cases with colorectal cancer including 3,089 early-onset cases, we examined microsatellite instability (MSI), CpG island methylator phenotype (CIMP), and KRAS and BRAF mutations in carcinomas of the cecum, ascending colon, transverse colon, descending colon, sigmoid colon, and rectum and compared early-onset cases with later-onset cases. RESULTS: The proportions of MSI-high, CIMP-high, and BRAF -mutated early-onset tumors were lowest in the rectum (8.8%, 3.4%, and 3.5%, respectively) and highest in the ascending colon (46% MSI-high; 15% CIMP-high) or transverse colon (8.6% BRAF -mutated) (all Ptrend <0.001 across the rectum to ascending colon). Compared with later-onset tumors, early-onset tumors showed a higher prevalence of MSI-high status and a lower prevalence of CIMP-high status and BRAF mutations in most subsites. KRAS mutation prevalence was higher in the cecum compared with that in the other subsites in both early-onset and later-onset tumors ( P < 0.001). Notably, later-onset MSI-high tumors showed a continuous decrease in KRAS mutation prevalence from the rectum (36%) to ascending colon (9%; Ptrend <0.001), followed by an increase in the cecum (14%), while early-onset MSI-high cancers showed no such trend. DISCUSSION: Our findings support biogeographical and pathogenic heterogeneity of colorectal carcinomas in different colorectal subsites and age groups.
引用
- Ugai T, Haruki K, Harrison TA, et al. Molecular Characteristics of Early-Onset Colorectal Cancer According to Detailed Anatomical Locations: Comparison With Later-Onset Cases. Am J Gastroenterol. 2022. PMID: 36707929. doi:10.14309/ajg.0000000000002171
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。